| SLP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SLP shares outstanding history going back to 1/12/2010:
Also see: SLP Market Cap History SLP YTD Return |
As of 6/30/2026 Simulations Plus has 20.22 million SLP shares outstanding. Investors often track the SLP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SLP share count trends over time, with 69 historical shares outstanding datapoints presented, dating back to 1/12/2010.

| SLP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SLP shares outstanding history going back to 1/12/2010:
Also see: SLP Market Cap History SLP YTD Return |
| SLP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLP Historical Shares Outstanding: +1.56% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SLP Stock Price Chart |
| About Simulations Plus Inc |
| Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. We show 69 historical shares outstanding datapoints in our coverage of SLP's shares outstanding history. Understanding the changing numbers of SLP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SLP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SLP by allowing them to research SLP shares outstanding history as well as any other stock in our coverage universe. |
| SLP Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| SLP Share Performance |
| Shares Outstanding Peers |
| Simulations Plus (SLP) is categorized under the Technology sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SMAR Shares Outstanding History SMCI Shares Outstanding History SMIT Shares Outstanding History SMRT Shares Outstanding History SMSI Shares Outstanding History SMTC Shares Outstanding History SNAL Shares Outstanding History SNAP Shares Outstanding History SNCR Shares Outstanding History SNDK Shares Outstanding History More Technology companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.